We are live on ! Find out more
Pictet Asset Management

Pictet Asset Management Portfolio holdings

AUM $105B
1-Year Est. Return 38.07%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
10 Year Est. Return
AUM
$87.3B
AUM Growth
-$4.6B
Cap. Flow
-$5.51B
Cap. Flow %
-6.32%
Top 10 Hldgs %
18.42%
Holding
2,054
New
81
Increased
677
Reduced
810
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Industrials 17.72%
3 Healthcare 13.34%
4 Consumer Discretionary 7.59%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNG icon
151
RingCentral
RNG
$5.38B
$142M 0.16%
5,038,757
-169,908
-3% -$5.46M
WY icon
152
Weyerhaeuser
WY
$18.2B
$142M 0.16%
4,993,675
-756,665
-13% -$23.4M
IDXX icon
153
Idexx Laboratories
IDXX
$46.9B
$141M 0.16%
289,418
+5,293
+2% +$2.66M
VRT icon
154
Vertiv
VRT
$104B
$141M 0.16%
1,625,404
-661,904
-29% -$60.3M
QCOM icon
155
Qualcomm
QCOM
$170B
$139M 0.16%
700,324
+19,406
+3% +$3.67M
DDOG icon
156
Datadog
DDOG
$93.6B
$138M 0.16%
1,064,723
+421,756
+66% +$51M
OTIS icon
157
Otis Worldwide
OTIS
$27.7B
$138M 0.16%
1,430,245
-105,650
-7% -$10.2M
JCI icon
158
Johnson Controls International
JCI
$91.2B
$137M 0.16%
2,066,922
-682,230
-25% -$45.9M
BMRN icon
159
BioMarin Pharmaceuticals
BMRN
$13.3B
$137M 0.16%
1,663,163
-242,446
-13% -$20.2M
ABBV icon
160
AbbVie
ABBV
$438B
$136M 0.16%
793,230
-63,786
-7% -$10.6M
ARGX icon
161
argenx
ARGX
$54.2B
$133M 0.15%
308,176
-20,992
-6% -$8.03M
MRNA icon
162
Moderna
MRNA
$23.9B
$132M 0.15%
1,114,162
-1,507,475
-58% -$191M
PNW icon
163
Pinnacle West Capital
PNW
$12B
$131M 0.15%
1,712,299
-94,180
-5% -$7.11M
PEP icon
164
PepsiCo
PEP
$188B
$131M 0.15%
792,562
-76,646
-9% -$13.2M
AVTR icon
165
Avantor
AVTR
$9.29B
$128M 0.15%
6,026,227
+197,444
+3% +$4.75M
RVTY icon
166
Revvity
RVTY
$13B
$123M 0.14%
1,171,619
-92,899
-7% -$9.86M
BAC icon
167
Bank of America
BAC
$447B
$123M 0.14%
3,081,990
-32,359
-1% -$1.24M
UNP icon
168
Union Pacific
UNP
$174B
$122M 0.14%
540,829
-347,431
-39% -$81.4M
D icon
169
Dominion Energy
D
$59B
$122M 0.14%
2,495,307
-242,200
-9% -$12.3M
BPMC
170
DELISTED
Blueprint Medicines
BPMC
$122M 0.14%
1,127,302
-737,236
-40% -$73.8M
ELV icon
171
Elevance Health
ELV
$86.2B
$120M 0.14%
221,866
+5,663
+3% +$2.99M
CSCO icon
172
Cisco
CSCO
$483B
$120M 0.14%
2,528,817
-1,262,373
-33% -$59.9M
NBIX icon
173
Neurocrine Biosciences
NBIX
$16.8B
$120M 0.14%
871,324
-210,125
-19% -$28.8M
BIDU icon
174
Baidu
BIDU
$37.1B
$116M 0.13%
1,343,329
+12,601
+0.9% +$1.27M
IONS icon
175
Ionis Pharmaceuticals
IONS
$9.46B
$115M 0.13%
2,409,954
-1,329,803
-36% -$54.5M

Similar funds

Pictet Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Pictet Asset Management held 2,054 positions worth $87.3B, down 5% from $91.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pictet Asset Management withdrew a net $5.51B in Q2 2024, closing 85 positions and reducing 810 holdings. Its most notable exit was Immunocore, an estimated $45.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Pictet Asset Management opened a new position in iShares TIPS Bond ETF worth $35.1M.

  • Pictet Asset Management's largest Q2 2024 buy was iShares TIPS Bond ETF: 327,700 shares worth $35.1M.
  • Pictet Asset Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $571M increase.
  • Pictet Asset Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $881M.
  • Pictet Asset Management fully exited Immunocore in Q2 2024, selling an estimated $45.9M.
  • Pictet Asset Management's ten largest holdings make up 18% of its $87.3B portfolio in Q2 2024.
  • Pictet Asset Management opened 81 new positions and closed 85 in Q2 2024.
  • Pictet Asset Management's portfolio value fell 5% quarter-over-quarter to $87.3B.

Based on Pictet Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.